FR2354340B1 - - Google Patents

Info

Publication number
FR2354340B1
FR2354340B1 FR7717655A FR7717655A FR2354340B1 FR 2354340 B1 FR2354340 B1 FR 2354340B1 FR 7717655 A FR7717655 A FR 7717655A FR 7717655 A FR7717655 A FR 7717655A FR 2354340 B1 FR2354340 B1 FR 2354340B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7717655A
Other versions
FR2354340A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2354340A1 publication Critical patent/FR2354340A1/fr
Application granted granted Critical
Publication of FR2354340B1 publication Critical patent/FR2354340B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7717655A 1976-06-09 1977-06-09 Procede pour la recuperation de l'antithrombine iii Granted FR2354340A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/694,167 US4087415A (en) 1976-06-09 1976-06-09 Antithrombin III

Publications (2)

Publication Number Publication Date
FR2354340A1 FR2354340A1 (fr) 1978-01-06
FR2354340B1 true FR2354340B1 (fr) 1982-09-10

Family

ID=24787683

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717655A Granted FR2354340A1 (fr) 1976-06-09 1977-06-09 Procede pour la recuperation de l'antithrombine iii

Country Status (4)

Country Link
US (1) US4087415A (fr)
JP (1) JPS52151710A (fr)
DE (1) DE2725711A1 (fr)
FR (1) FR2354340A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
JPS5699422A (en) * 1980-01-10 1981-08-10 Toyo Soda Mfg Co Ltd Separation of plasma albumin
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4446314A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Fractionation of heparin
US4386025A (en) * 1980-09-30 1983-05-31 Cutter Laboratories, Inc. Method of preparing antithrombin
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung
US4517294A (en) * 1982-03-03 1985-05-14 Genentech, Inc. Human antithrombin III
DE3381783D1 (de) * 1982-03-03 1990-09-13 Genentech Inc Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen.
US4632981A (en) * 1982-07-30 1986-12-30 Genentech, Inc. Human antithrombin III
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
JP2002526418A (ja) 1998-10-08 2002-08-20 チルドレンズ ホスピタル 血管形成を阻害するための組成物と方法
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
AU2010324839B2 (en) * 2009-11-24 2015-02-19 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma
US3839314A (en) * 1971-06-29 1974-10-01 Baxter Laboratories Inc Clarification of blood serum and plasma using block copolymers of ethylene oxide and polyoxypropylene
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US3880989A (en) * 1973-01-30 1975-04-29 Baxter Laboratories Inc Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US3850903A (en) * 1973-06-21 1974-11-26 S Mankarious Plasma volume expander prepared from cohn iv precipitate using block copolymers of ethylene oxide and polyoxypropylene

Also Published As

Publication number Publication date
US4087415A (en) 1978-05-02
FR2354340A1 (fr) 1978-01-06
JPS52151710A (en) 1977-12-16
DE2725711A1 (de) 1977-12-22

Similar Documents

Publication Publication Date Title
FR2354340B1 (fr)
CH637799B (fr)
FR2337443B1 (fr)
JPS5714769B2 (fr)
JPS5521120B2 (fr)
JPS559248Y2 (fr)
JPS5338372U (fr)
JPS52155387U (fr)
JPS5337570U (fr)
JPS5347506Y2 (fr)
JPS5520646Y2 (fr)
JPS5611323Y2 (fr)
JPS5710234B2 (fr)
JPS5350079U (fr)
JPS5318146U (fr)
JPS5295119U (fr)
JPS52152553U (fr)
JPS52135111U (fr)
CH621672GA3 (fr)
CH607969A5 (fr)
DD124688A1 (fr)
DD124632A1 (fr)
DD124533A1 (fr)
DD125729A2 (fr)
BE851837A (fr)

Legal Events

Date Code Title Description
CA Change of address
TP Transmission of property
ST Notification of lapse